• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Doug Kass
    • Bruce Kamich
    • Jim Cramer
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing
  3. / Stocks

Lam Research: Bearish Divergences Suggest Caution

Charts are delivering a warning to LRCX longs.
By BRUCE KAMICH
Feb 02, 2021 | 12:15 PM EST
Stocks quotes in this article: LRCX

Jim Cramer explained in his Real Money column "There's Good Risk and Bad Risk" that individual investors can still make money in the stock market without buying into the Reddit frenzy.

Cramer said that in volatile markets, it always pays to circle back to the fundamentals. This week, for example, we learned that there's a big shortage of semiconductors. That's great news for stocks like Lam Research (LRCX) and others.

The last time we reviewed the charts of LRCX was way back on May 7, when we wrote that, "LRCX is likely to trade sideways for the near-term but the longer-term view remains positive." LRCX did not resume its rally until June.

Let's check out the latest charts of LRCX.

In the updated daily bar chart of LRCX, below, we can see a correction in August/September before the current rally into January. Prices recently pulled back to test the rising 50-day moving average line. The 200-day moving average also has a positive slope.

The On-Balance-Volume (OBV) line has moved sideways in December and January as the shares made higher highs -- this is a bearish divergence and is a warning to longs. The 12-day price momentum study shows equal highs from November to January, which is another bearish divergence as prices made higher highs. Another heads up that the price action and the indicators are diverging.

In the weekly Japanese candlestick chart of LRCX, below, we can see a bearish candlestick top reversal pattern in January. Prices are above the rising 40-week moving average line but the weekly trading volume has been diminishing since March.

The OBV line has gone sideways the past year and has diverged from the price action. The Moving Average Convergence Divergence (MACD) oscillator has been narrowing in recent weeks and tells us that the trend strength has been weakening.

In this daily Point and Figure chart of LRCX, below, we can see a potential downside price target in the $390 area.

Bottom-line strategy: When you analyze an individual stock you should pay attention to the trend in the broader market to some degree. The charts of LRCX are showing weakness and bearish divergences despite the strength in the broader market most days. Longs need to be cautious in the weeks ahead -- a break of support around $475 will be bearish.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

Employees of TheStreet are prohibited from trading individual securities.

TAGS: Investing | Stocks | Technical Analysis | Semiconductors & Semiconductor Equipment | Mad Money

More from Stocks

Jim Cramer: The Sins of a Messianic Market

Jim Cramer
Apr 14, 2021 7:26 PM EDT

We have crypto worshipers, false idols and those who believe selling can equal betrayal.

S&P Loses Some Shine on Coinbase IPO

James "Rev Shark" DePorre
Apr 14, 2021 4:23 PM EDT

The initial public offering turned out to be a bit of a dud, but that may be what the market needs.

A High Yield Healthcare REIT for Income Investors

Bob Ciura
Apr 14, 2021 3:00 PM EDT

With projected returns in excess of 10% annually and a 5.9% dividend yield, National Health Investors is one of our favorites.

Amgen Looks Ready for an Upside Breakout

Bruce Kamich
Apr 14, 2021 2:45 PM EDT

Traders could go long at current levels risking below $240 for now.

Coinbase's Market Cap Is Too Huge for Competitors to Ignore It Any Longer

Timothy Collins
Apr 14, 2021 2:23 PM EDT

Yes, COIN is only one company, one stock, but it's a mountain of emotion right now.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 02:42 PM EDT PAUL PRICE

    Wednesday on Real Money Pro

    Make this stock a 'part' of your portfolio.
  • 04:44 PM EDT PAUL PRICE

    Pretty Incredible + Hard to Believe

  • 11:18 AM EDT JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    The 5 Pillars of Exceptional Trading
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2021 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login